Have a personal or library account? Click to login
Impact of dermatologic adverse reactions on QOL in oncologic patients: results from a single-center prospective study Cover

Impact of dermatologic adverse reactions on QOL in oncologic patients: results from a single-center prospective study

Romanian Journal of Internal Medicine
Volume 56 (2018): Issue 2 (June 2018)
By:
Open Access
|May 2018

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/rjim-2018-0002 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Journal RSS Feed
Language: English
Page range: 96 - 101
Submitted on: Jan 1, 2018
Published on: May 17, 2018
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
exanthema,
toxicity,
EGFR tyrosine kinase inhibitor,
quality of life,
chemotherapy
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Internal medicine, other,
Cardiology,
Gastroenterology,
Rheumatology

© 2018 Maria Alexandra Barbu, Cornelia Niţipir, Theodor Voiosu, Călin Giurcăneanu, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 56 (2018): Issue 2 (June 2018)Next article